Stephen H. Ensley

Splunk is helping to build a safer and more resilient digital world by equipping customers with the unified security and observability platform they need to keep their organization securely up and running — no matter what digital disruptions come their way.

Immense opportunities are within reach. X-Chem is the partner you need to unlock exponential possibilities in your small molecule drug discovery. We empower you to screen billions of compounds against your target with our groundbreaking DNA-encoded library (DEL) screening platform. No other partner understands DEL like X-Chem — our experts invented DEL-driven drug discovery and will help you leverage it with unprecedented speed and clarity. Small molecules hold exponential possibilities. Find your next candidate with X-Chem. We have demonstrated our success both internally and with external partnerships by tackling some of the most difficult, intractable targets such as: -protein:protein interactions (PPI) -antibacterial targets -ubiquitin ligases -epigenetic targets -GPCRs We have established collaborations with eight of the leading pharmaceutical companies in the world, including among others: Roche, AstraZeneca, Bayer and Pfizer. We also have partnerships with top tier biotechnology companies, academic centers and non-profit institutions. We have generated novel lead compounds against dozens of high-value therapeutic targets, leading to licensing of multiple lead series by our partners.

Genesys empowers organizations of all sizes to improve loyalty and business outcomes by creating the best experiences for their customers and employees. Through Genesys Cloud, the AI-Powered Experience Orchestration platform, organizations can accelerate growth by delivering empathetic, personalized experiences at scale to drive customer loyalty, workforce engagement, efficiency and operational improvements. Visit www.genesys.com.

PPD is part of Thermo Fisher Scientific, the world leader in serving science. Together, Thermo Fisher and its PPD clinical research business are creating a unique opportunity to advance their shared pursuit to enable customers to make the world healthier by accelerating the development of new medicines. We offer a comprehensive suite of world-class services across the clinical development spectrum – from scientific discovery, to assessing safety, efficacy, and health care outcomes, to managing clinical trial logistics, to the development and manufacturing of the drug product.

For more than forty years, AlixPartners has helped businesses around the world respond quickly and decisively to their most critical challenges – circumstances as diverse as urgent performance improvement, accelerated transformation, complex restructuring and risk mitigation. These are the moments when everything is on the line – a sudden shift in the market, an unexpected performance decline, a time-sensitive deal, a fork-in-the-road decision. But it’s not what we do that makes a difference, it’s how we do it. Tackling situations when time is of the essence is part of our DNA – so we adopt an action-oriented approach at all times. We work in small, highly qualified teams with specific industry and functional expertise, and we operate at pace, moving quickly from analysis to implementation. We stand shoulder to shoulder with our clients until the job is done, and only measure our success in terms of the results we deliver. Our approach enables us to help our clients confront and overcome truly future-defining challenges. We partner with you to make the right decisions and take the right actions. And we are right by your side. When it really matters. Recent Awards & Recognition: - Best Firm to Work For – Consulting Magazine, 2023 - Best Places to Work For LGBTQ+ Equality – Human Rights Campaign, 2022 - Best Management Consulting Firms – Forbes, 2021 - Ranked in the Top 10 in UHLALA Group’s Pride Index

Zendesk powers exceptional service for every person on the planet. As a leader in AI-powered service, we offer the Zendesk Resolution Platform, designed to redefine customer experience with advanced tools that integrate AI Agents, a comprehensive knowledge graph, actions and integrations, governance and control, measurement and insights, and human expertise. Our purpose-built platform enhances service by combining automation and human insight for seamless interactions. Easy to use, easy to scale, and easy to get value from, Zendesk helps companies strengthen relationships, improve efficiency, and grow. Learn more: http://zdsk.co/46mVi8h

Splunk is helping to build a safer and more resilient digital world by equipping customers with the unified security and observability platform they need to keep their organization securely up and running — no matter what digital disruptions come their way.

Checkmarx helps the world’s largest enterprises get ahead of application risk without slowing down development. We end the guesswork by identifying the most critical issues to fix and give AppSec the tools they need, all while letting developers work the way they want. From DevSecOps to developer experience, security and development teams can now work better together. That’s why 1700+ customers rely on Checkmarx to scan over 1 trillion lines of code annually, improve developer productivity by 50%, and deliver 2X AppSec ROI. Checkmarx. Always Ready To Run.

Sprinklr is the definitive, AI-native platform for Unified Customer Experience Management (Unified-CXM), empowering brands to deliver extraordinary experiences at scale — across every customer touchpoint. By combining human instinct with the speed and efficiency of AI, Sprinklr helps brands earn trust and loyalty through personalized, seamless, and efficient customer interactions. Sprinklr’s unified platform provides powerful solutions for every customer-facing team — spanning social media management, marketing, advertising, customer feedback, and omnichannel contact center management — enabling enterprises to unify data, break down silos, and act on real-time insights. Today, 1,900+ enterprises — including Microsoft, P&G, Samsung, and 60% of the Fortune 100 — rely on Sprinklr to help them deliver consistent, trusted customer experiences worldwide.

Immense opportunities are within reach. X-Chem is the partner you need to unlock exponential possibilities in your small molecule drug discovery. We empower you to screen billions of compounds against your target with our groundbreaking DNA-encoded library (DEL) screening platform. No other partner understands DEL like X-Chem — our experts invented DEL-driven drug discovery and will help you leverage it with unprecedented speed and clarity. Small molecules hold exponential possibilities. Find your next candidate with X-Chem. We have demonstrated our success both internally and with external partnerships by tackling some of the most difficult, intractable targets such as: -protein:protein interactions (PPI) -antibacterial targets -ubiquitin ligases -epigenetic targets -GPCRs We have established collaborations with eight of the leading pharmaceutical companies in the world, including among others: Roche, AstraZeneca, Bayer and Pfizer. We also have partnerships with top tier biotechnology companies, academic centers and non-profit institutions. We have generated novel lead compounds against dozens of high-value therapeutic targets, leading to licensing of multiple lead series by our partners.